FDA Issues Observation Letter to Lupin Plant
Resilinc-blog

According to The Hindu Business Line, the United States Food and Drug Administration (FDA) issued a Form 483 to Lupin Ltd. in Pithampur, Indore, India, as reported on Saturday, January 26.

Read All Global Disruptions

Recent Global Disruptions